Cite Filings / JSPR / 0001213900-25-089581
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Jasper Therapeutics, Inc. · Filed 2025-09-19 · Acc 0001213900-25-089581

Documents 1

  • 424B5 Prospectus , ea0258024-424b5_jasper.htm

Around this filing

  • 2025-09-24 4 Director bought 41,000 shares at $2.43 ($99,630)
  • 2025-09-24 4 President and CEO bought 41,000 shares at $2.43 ($99,630)
  • 2025-09-24 4 Director bought 41,000 shares at $2.43 ($99,630)
  • 2025-09-23 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-09-19 8-K Material agreement · Other events
  • 2025-09-19 424B5 Prospectus
  • 2025-09-18 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading ea0258024-424b5_jasper.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…